Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients
Clinical trial NCT04778176 · COMPLETED
Trial details
- NCT number
- NCT04778176
- Sponsor
- SynAgile Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2022-07-21
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.